Dermatitis: all 1,425 studies
Page 11 of 15. Open to participants first (127), then studies with results posted, then the rest; newest registration first within each.
- Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT02896101Phase 3
- Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic DermatitisCompletedNCT02888704Phase 1
- Animal Allergy in Korean Veterinary ResearcherCompletedNCT02866864
- Topical Solution for the Treatment of Atopic DermatitisCompletedNCT02865356Phase 2
- To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic SkinCompletedNCT02857062Not applicable
- Antipruritic Effect of Acupuncture in Patients With Atopic DermatitisCompletedNCT02844452Not applicable
- Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host DiseaseWithdrawnNCT02842372
- The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic DermatitisCompletedNCT02840955Not applicable
- Study of Autologous Total Immunoglobulin G Therapy for Atopic DermatitisCompletedNCT02835170Phase 2/3
- Texting Atopic Dermatitis Patients to Optimize Learning and EASI ScoresCompletedNCT02779426Not applicable
- Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis TherapyStatus unknownNCT02763722Not applicable
- ALDH2 Mutation in Taiwanese Head and Neck CancerStatus unknownNCT02761408
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic DermatitisCompletedNCT02757729Phase 2
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic DermatitisCompletedNCT02749383Phase 2
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic DermatitisCompletedNCT02748993Phase 1/2
- First in Human of Single and Multiple Doses of MOR106CompletedNCT02739009Phase 1
- Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic DermatitisCompletedNCT02732314Phase 4
- Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRTStatus unknownNCT02729324Phase 2
- Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and InfantsCompletedNCT02716415Phase 4
- Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic DermatitisCompletedNCT02716181Not applicable
- Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema PatientsTerminatedNCT02713035Not applicable
- A Phase I, Single-Center Study of PDC-APB in Healthy VolunteersCompletedNCT02700373Phase 1
- Pressure Ulcer Prevention: a Turn and Positioning System Combined With Incontinence Care and Tailored/Standard RepositioningCompletedNCT02690753Not applicable
- Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677636Phase 3
- Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677610Phase 3
- Indigo Naturalis in Treating Atopic Dermatitis TopicallyCompletedNCT02669888Phase 2
- Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic DermatitisCompletedNCT02656368Not applicable
- Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)CompletedNCT02647086Phase 1
- Skin Irritation Study of GSK2894512 CreamCompletedNCT02637206Phase 1
- A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 MonthsTerminatedNCT02634905Not applicable
- An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical CorticosteroidsCompletedNCT02627989
- A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to SurfactantsCompletedNCT02615912Not applicable
- Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic ProductCompletedNCT02615561Not applicable
- To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)CompletedNCT02601703Phase 3
- The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic DermatitisCompletedNCT02594969Not applicable
- A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult SubjectsCompletedNCT02590289Phase 1
- Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young PatientsCompletedNCT02585986Not applicable
- A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic DermatitisCompletedNCT02583022Phase 2
- Bathing Additives in Pediatric Atopic DermatitisTerminatedNCT02582788Not applicable
- Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant RadiotherapyStatus unknownNCT02580279Phase 2
- BM Collection From NICU Infants for CompositionCompletedNCT02570698
- Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal IrritationsCompletedNCT02558738
- Atopy Patch Test in Children With Atopic DermatitisCompletedNCT02552979
- PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. PlaceboCompletedNCT02537509Phase 2
- Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?CompletedNCT02534467Phase 4
- Epidemiology and Co-Reactivity of Novel Surfactant AllergensCompletedNCT02534441Not applicable
- The Natural History of Atopic Disease in Thai Children and Association With Atopic MarchCompletedNCT02532920
- Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in ChildrenCompletedNCT02519556Phase 4
- An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02496546Phase 1
- Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' PatientsStatus unknownNCT02495064Phase 4
- Cutaneous and Systemic Reactions to Metal ImplantsTerminatedNCT02483728Not applicable
- Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in ElderlyTerminatedNCT02475512Not applicable
- Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic DermatitisCompletedNCT02475447Phase 2
- Pharmacokinetic Study of Topical GSK2894512 CreamCompletedNCT02466152Phase 1
- A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic DermatitisCompletedNCT02465606Phase 2
- Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic DermatitisCompletedNCT02456480Phase 2
- Preventing Atopic Dermatitis and ALLergies in ChildrenActive, not recruitingNCT02449850Not applicable
- Phase 1 Study of LevocetirizineCompletedNCT02447393Phase 1
- Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT02426359Phase 2
- A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 CreamCompletedNCT02411162Phase 1
- The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in InfantsCompletedNCT02401178
- A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic DermatitisCompletedNCT02379910Phase 1/2
- A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02376049Phase 1
- Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic DermatitisTerminatedNCT02369432Early Phase 1
- Neurobiology of the Scalp in Seborrheic DermatitisCompletedNCT02349854
- A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisCompletedNCT02345928Phase 1
- The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic DermatitisCompletedNCT02343861Not applicable
- A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCompletedNCT02343783Early Phase 1
- A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic DermatitisCompletedNCT02340234Phase 2
- Cognitive Behavior Therapy for Atopic DermatitisCompletedNCT02302625Not applicable
- Role of Anti-IgE in Severe Childhood EczemaCompletedNCT02300701Phase 4
- Probiotic Supplementation in Breastfed Newborn InfantsWithdrawnNCT02286999Phase 1
- Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic DermatitisStatus unknownNCT02286700Phase 3
- Inflammatory Cells From Various PathologiesCompletedNCT02270411
- Treatment of Chronic Itch in Atopic Dermatitis (Eczema): Nerve FunctionCompletedNCT02268448Phase 1
- Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer PatientsCompletedNCT02261181Not applicable
- 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic DermatitisWithdrawnNCT02241174Phase 1
- Photophoresis Versus Ciclosporine in Severe Atopic DermatitisCompletedNCT02226068Not applicable
- Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate EczemaWithdrawnNCT02224950Not applicable
- Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02219633Phase 1
- Haut-Tief Patient Education on Psoriasis and EczemaStatus unknownNCT02205593Not applicable
- Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment AdherenceCompletedNCT02193230
- WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis PatientsCompletedNCT02182570Phase 3
- WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis PatientsCompletedNCT02182557Phase 3
- Effect of Holly Mangrove Shower Gel in Atopic Dermatitis PatientsCompletedNCT02178215Phase 3
- Study to Determine the Pharmacokinetics of Product 0405WithdrawnNCT02176577Phase 3
- Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric SubjectsWithdrawnNCT02176538Phase 3
- Atopic Dermatitis Adherence StudyStatus unknownNCT02169986Not applicable
- KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast CancerWithdrawnNCT02168179Not applicable
- Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus CreamCompletedNCT02153762Not applicable
- Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisCompletedNCT02148744Phase 1
- Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis PatientsWithdrawnNCT02144142Phase 2
- Protopic Adherence and Efficacy in Korean Eczema PatientCompletedNCT02126176
- Pilot Tape Harvesting StudyCompletedNCT02125695
- Prebiotics in Prevention of AtopyCompletedNCT02116452Phase 3
- ADRN Barrier/Immunoprofiling Exploratory Pilot StudyCompletedNCT02115399
- Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic DermatitisCompletedNCT02103972Not applicable
- A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic DermatitisCompletedNCT02103725Phase 1
- Investigating Immune Mechanisms in Atopic EczemaWithdrawnNCT02102841Not applicable
- Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 FragmentsCompletedNCT02098551